Betaine Homocysteine Methyltransferase Is Active in the Mouse Blastocyst and Promotes Inner Cell Mass Development
Methyltransferases are an important group of enzymes with diverse roles that include epigenetic gene regulation. The universal donor of methyl groups for methyltransferases is S-adenosylmethionine (AdoMet), which in most cells is synthesized using methyl groups carried by a derivative of folic acid....
Saved in:
Published in | The Journal of biological chemistry Vol. 287; no. 39; pp. 33094 - 33103 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Elsevier Inc
21.09.2012
American Society for Biochemistry and Molecular Biology |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Methyltransferases are an important group of enzymes with diverse roles that include epigenetic gene regulation. The universal donor of methyl groups for methyltransferases is S-adenosylmethionine (AdoMet), which in most cells is synthesized using methyl groups carried by a derivative of folic acid. Another mechanism for AdoMet synthesis uses betaine as the methyl donor via the enzyme betaine-homocysteine methyltransferase (BHMT, EC 2.1.1.5), but it has been considered to be significant only in liver. Here, we show that mouse preimplantation embryos contain endogenous betaine; Bhmt mRNA is first expressed at the morula stage; BHMT is abundant at the blastocyst stage but not other preimplantation stages, and BHMT activity is similarly detectable in blastocyst homogenates but not those of two-cell or morula stage embryos. Knockdown of BHMT protein levels and reduction of enzyme activity using Bhmt-specific antisense morpholinos or a selective BHMT inhibitor resulted in decreased development of embryos to the blastocyst stage in vitro and a reduction in inner cell mass cell number in blastocysts. The detrimental effects of BHMT knockdown were fully rescued by the immediate methyl-carrying product of BHMT, methionine. A physiological role for betaine and BHMT in blastocyst viability was further indicated by increased fetal resorption following embryo transfer of BHMT knockdown blastocysts versus control. Thus, mouse blastocysts are unusual in being able to generate AdoMet not only by the ubiquitous folate-dependent mechanism but also from betaine metabolized by BHMT, likely a significant pool of methyl groups in blastocysts.
Background: Blastocyst stage embryos require a large pool of methyl groups, but the source is unknown.
Results: Betaine-homocysteine methyltransferase (BHMT), which takes methyl groups from betaine, is highly active in mouse blastocysts and promotes development of cells that become the fetus.
Conclusion: BHMT contributes to the methyl pool in the blastocyst.
Significance: Betaine and BHMT promote embryo development. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Recipient of a Canadian Institutes of Health Research studentship. James McGill Professor of McGill University. Supported by a Lalor Foundation postdoctoral fellowship. Supported in part by the Program on Oocyte Health funded by Canadian Institutes of Health Research Institute of Human Development Child and Youth Health Strategic Initiative Grant HGG62293. Member of the Research Institute of the McGill University Health Centre, which is supported in part by the Fonds de la Recherche en Santé du Québec. |
ISSN: | 0021-9258 1083-351X |
DOI: | 10.1074/jbc.M112.365478 |